Pharmaceutical consultants apply their comprehensive expertise in different areas to accelerate the drug development process.

BullFrog AI plans to introduce what it considers a game-changing approach that could shorten timelines, reduce costs, and increase success rates in drug development.

side-effect profile and so on before confirming the lessons learned with only compounds deemed to have good chances of success in Phase III trials is not a new paradigm in drug development ...

Vivace Therapeutics has closed $35m in a Series D financing round to support the clinical development of its cancer drug ...

The investment of over $6 million will expand LGM Pharma’s Rosenberg, Texas manufacturing facility as part of its Phase I ...

Drugs in later phases are more likely to succeed ... Most biotech companies have many drugs simultaneously under development, which provides multiple revenue streams. The safest biotech ...

Pheiron and Ribo are excited to announce that the first two strategic collaboration milestones have been successfully ...

New SEC filings from pharmaceutical companies reveal Donald Trump and Elon Musk’s cost-cutting measures could slow drug ...

Mineralys’ shares got a more than 50% boost Monday morning as new data showed its hypertension drug reduced blood pressure in ...

Patients enroll in phase 2 oncology trials seeking access to promising new treatments, but the risk-benefit assessments and ...